Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75, & 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.

Condition:   Menopause Intervention:   Drug: Estrogel Sponsors:   Viramal Limited;   Simbec Research Recruiting

Source: ClinicalTrials.gov - June 14, 2018 Category: Research Source Type: clinical trials